CN Stock MarketDetailed Quotes
300030 Improve Medical Instruments
- 5.69
- -0.19-3.23%
Post Market Dec 25 15:00 CST
1.76BMarket Cap-16.16P/E (TTM)
6.12High5.65Low92.18KlotVolume6.00Open5.88Pre Close53.21MTurnover3.39%Turnover RatioLossP/E (Static)309.19MShares8.3052wk High2.59P/B1.55BFloat Cap3.3152wk Low7.06Limit Up272.22MShs Float37.88Historical High4.70Limit Down7.99%Amplitude3.24Historical Low--Dividend TTM5.77Avg Price51.20KlotAsk--Div YieldTTM100Lot Size38.79KlotBid
Improve Medical Instruments Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -10.78%421.47M | -8.32%293.16M | -10.98%141.15M | -9.31%644.62M | -10.79%472.4M | -9.27%319.76M | -11.69%158.56M | -11.14%710.77M | -10.19%529.55M | -15.33%352.43M |
| Operating revenue | -10.78%421.47M | -8.32%293.16M | -10.98%141.15M | -9.31%644.62M | -10.79%472.4M | -9.27%319.76M | -11.69%158.56M | -11.14%710.77M | -10.19%529.55M | -15.33%352.43M |
| Other operating revenue | ---- | -27.04%2.25M | ---- | 68.58%9.45M | ---- | -13.82%3.08M | ---- | -4.29%5.61M | ---- | 35.66%3.57M |
| Total operating cost | -13.38%413.93M | -10.52%287.44M | -12.20%136.27M | -10.27%675.45M | -10.26%477.87M | -7.38%321.22M | -12.80%155.2M | -2.26%752.78M | -4.03%532.51M | -10.53%346.82M |
| Operating cost | -11.66%252.7M | -9.31%175.78M | -11.98%85.05M | -13.90%384.3M | -11.34%286.06M | -7.98%193.82M | -7.67%96.62M | -5.70%446.35M | -5.52%322.63M | -10.20%210.62M |
| Operating tax surcharges | 6.20%6.47M | 3.04%4.84M | 71.31%3.16M | 7.53%8.52M | 13.11%6.09M | 31.34%4.7M | -7.14%1.84M | -21.19%7.92M | -22.65%5.38M | -22.58%3.58M |
| Operating expense | -23.99%57.98M | -18.63%41.16M | -17.41%18.4M | -3.20%122.02M | -5.01%76.28M | -1.98%50.58M | -18.59%22.28M | 11.60%126.05M | 1.30%80.3M | -9.56%51.6M |
| Administration expense | -9.57%65.67M | -1.81%46.31M | 6.60%21.47M | -5.84%106.74M | -13.80%72.61M | -11.60%47.16M | -27.64%20.14M | 6.64%113.35M | 3.84%84.24M | -11.86%53.35M |
| Financial expense | -23.96%7.74M | -24.80%5.25M | -68.52%1.59M | 5.88%16.35M | 9.58%10.17M | -13.89%6.99M | -26.55%5.06M | -38.89%15.45M | -49.84%9.28M | -39.40%8.11M |
| -Interest expense (Financial expense) | -16.70%9.29M | -11.71%6.92M | -48.85%2.08M | -15.91%16.56M | -25.35%11.15M | -29.85%7.84M | -39.74%4.06M | -22.57%19.7M | -18.33%14.94M | -13.24%11.17M |
| -Interest Income (Financial expense) | 14.87%-1.43M | 17.77%-974.97K | 8.66%-453.01K | 5.67%-2.32M | 8.75%-1.68M | 18.71%-1.19M | -9.08%-495.96K | -17.76%-2.45M | -37.44%-1.84M | -78.00%-1.46M |
| Research and development | -12.32%23.38M | -21.53%14.11M | -28.69%6.6M | -14.07%37.52M | -13.06%26.66M | -8.12%17.98M | 0.05%9.26M | 3.16%43.67M | 11.35%30.67M | 11.77%19.57M |
| Credit Impairment Loss | -502.90%-6.49M | 37.28%-675.55K | ---- | 103.45%369.1K | 74.07%-1.08M | 74.10%-1.08M | --400 | 19.54%-10.7M | -846.43%-4.15M | -847.13%-4.16M |
| Asset Impairment Loss | 95.61%-166.75K | -98.70%6.01K | ---- | 70.27%-35.05M | -2,525.38%-3.8M | 195.19%462.76K | ---- | -463.58%-117.89M | 101.63%156.77K | 101.49%156.77K |
| Other net revenue | -458.14%-48.42M | -158.17%-8.53M | -150.65%-6.28M | 94.16%-9.98M | 127.58%13.52M | 138.54%14.67M | 133.53%12.4M | -63,289.74%-170.83M | -910.04%-49.01M | -155.63%-38.05M |
| Fair value change income | ---35.18M | --0 | ---- | 120.28%1.21M | --0 | --0 | ---- | -172.66%-5.95M | ---- | ---- |
| Invest income | -272.08%-12.98M | -213.12%-12.3M | -185.00%-8.95M | 113.23%6.24M | 114.19%7.54M | 127.59%10.87M | 126.51%10.53M | -352.47%-47.14M | -1,631.77%-53.17M | -155.94%-39.42M |
| -Including: Investment income associates | -296.37%-14.38M | -241.00%-15.09M | -188.17%-9.07M | 111.81%5.68M | 113.63%7.32M | 126.87%10.7M | 125.71%10.29M | -1,118.45%-48.12M | -455.81%-53.72M | -163.99%-39.82M |
| Asset deal income | -91.52%384.11K | 191.45%412.36K | 219.52%612.9K | 1,371.27%6.45M | 3,905.07%4.53M | -442.85%-450.89K | ---512.83K | 2,718.77%438.73K | -495.40%-119K | -282.40%-83.06K |
| Other revenue | -4.83%6.02M | -17.06%4.03M | -13.66%2.06M | 3.62%10.8M | -23.52%6.33M | -10.81%4.86M | -1.64%2.38M | 36.99%10.42M | -24.96%8.27M | -25.36%5.44M |
| Operating profit | -608.28%-40.88M | -121.30%-2.81M | -108.84%-1.39M | 80.82%-40.81M | 115.48%8.04M | 140.70%13.21M | 144.53%15.76M | -812.21%-212.84M | -227.25%-51.97M | -133.44%-32.45M |
| Add:Non operating Income | -31.65%67.91K | -53.35%41.27K | -86.39%18.57K | 290.14%1.09M | -56.85%99.35K | -61.53%88.48K | 85.73%136.42K | 148.29%279.32K | 171.33%230.25K | 171.03%229.99K |
| Less:Non operating expense | 63.01%529.16K | 201.06%366.8K | 117,236.59%240.47K | 92.39%3.34M | -64.64%324.62K | -77.68%121.84K | -98.77%204.94 | -71.81%1.74M | -23.37%918.1K | -51.90%545.98K |
| Total profit | -628.83%-41.34M | -123.83%-3.14M | -110.16%-1.62M | 79.91%-43.06M | 114.85%7.82M | 140.21%13.17M | 144.99%15.9M | -998.88%-214.3M | -232.54%-52.65M | -134.14%-32.76M |
| Less:Income tax cost | 45.29%3.29M | -15.36%1.37M | -26.44%1.27M | 181.68%17.16M | -21.88%2.27M | -29.59%1.62M | -12.41%1.73M | -615.89%-21.01M | -46.89%2.9M | -61.56%2.3M |
| Net profit | -904.12%-44.63M | -138.99%-4.51M | -120.38%-2.89M | 68.84%-60.22M | 109.99%5.55M | 132.97%11.56M | 137.97%14.17M | -1,077.76%-193.29M | -262.15%-55.55M | -138.95%-35.06M |
| Net profit from continuing operation | -904.12%-44.63M | -138.99%-4.51M | -120.38%-2.89M | 68.84%-60.22M | 109.99%5.55M | 132.97%11.56M | 137.97%14.17M | -1,077.76%-193.29M | -262.15%-55.55M | -138.95%-35.06M |
| Less:Minority Profit | -189.40%-2.11M | -29.62%768.85K | -43.43%303.21K | -40.44%2.98M | 5.25%2.37M | 20.33%1.09M | 36.77%535.98K | 317.35%5.01M | 1,171.82%2.25M | 355.11%907.85K |
| Net profit of parent company owners | -1,434.95%-42.52M | -150.41%-5.28M | -123.40%-3.19M | 68.13%-63.2M | 105.51%3.18M | 129.10%10.46M | 136.16%13.63M | -1,167.94%-198.3M | -269.58%-57.8M | -140.05%-35.97M |
| Earning per share | ||||||||||
| Basic earning per share | -1,500.00%-0.14 | -166.67%-0.02 | -125.00%-0.01 | 68.75%-0.2 | 105.26%0.01 | 125.00%0.03 | 133.33%0.04 | -1,166.67%-0.64 | -272.73%-0.19 | -141.38%-0.12 |
| Diluted earning per share | -1,500.00%-0.14 | -166.67%-0.02 | -125.00%-0.01 | 68.75%-0.2 | 105.26%0.01 | 125.00%0.03 | 133.33%0.04 | -1,166.67%-0.64 | -272.73%-0.19 | -141.38%-0.12 |
| Other composite income | 1,618.03%17.68K | 278.64%11.42K | 880.90%13.78K | 138.59%1.94M | 98.07%-1.16K | 122.01%3.02K | 103.62%1.41K | 15.94%-5.03M | -112.96%-60.44K | 79.80%-13.7K |
| Other composite income of parent company owners | 1,618.03%17.68K | 278.64%11.42K | 880.90%13.78K | 138.59%1.94M | 98.07%-1.16K | 122.01%3.02K | 103.62%1.41K | 15.94%-5.03M | -112.96%-60.44K | 79.80%-13.7K |
| Other composite income of minority owners | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Total composite income | -903.97%-44.61M | -138.88%-4.5M | -120.28%-2.87M | 70.61%-58.28M | 109.98%5.55M | 132.96%11.56M | 137.94%14.17M | -1,538.12%-198.32M | -262.46%-55.61M | -139.00%-35.07M |
| Total composite income of parent company owners | -1,434.88%-42.5M | -150.29%-5.26M | -123.30%-3.18M | 69.87%-61.26M | 105.50%3.18M | 129.09%10.47M | 136.12%13.64M | -1,715.00%-203.33M | -269.90%-57.86M | -140.09%-35.98M |
| Total composite income of minority owners | -189.40%-2.11M | -29.62%768.85K | -43.43%303.21K | -40.44%2.98M | 5.25%2.37M | 20.33%1.09M | 36.77%535.98K | 317.35%5.01M | 1,171.82%2.25M | 355.11%907.85K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
